Vaccine companies develop biological products that train the immune system to recognise and respond to infectious agents, cancer-associated targets and other disease-related antigens. Their work spans human health, veterinary medicine and preparedness for emerging pathogens.
This category includes companies working on:
Browse 69 UK vaccine companies below.
Global viral vector CDMO for cell and gene therapy
Oxford Biomedica (OXB) is a global contract development and manufacturing organisation specialising in viral vectors for cell and gene therapy. The company provides lentiviral, adeno-associated virus (AAV), and adenoviral vector development and manufacturing services from early-stage process development through to…
Global biopharma with UK manufacturing, commercial and clinical operations
MSD is a global biopharmaceutical company discovering, developing, manufacturing and marketing medicines and vaccines across oncology, infectious disease, immunology, cardiometabolic disease and animal health. Its UK operations span pharmaceutical manufacturing at Cramlington, Northumberland, which supplies medicines…
Global pharma company in immunology, vaccines, and oncology
GSK is a multinational biopharmaceutical company engaged in the research, development, manufacture, and commercialisation of medicines and vaccines. Its pipeline and portfolio span respiratory and immunology, oncology, HIV (through its specialist subsidiary ViiV Healthcare), and infectious diseases including vaccines.…
Silica encapsulation platform eliminating cold chain for biologics
EnsiliTech is a biotechnology company developing ensilication, a patented platform technology that encases vaccines, antibodies, and other biologics within a silica matrix to render them thermally stable without refrigeration. The technology is applicable to existing and new biopharmaceutical formulations, enabling…
One-step encapsulation drug delivery platform for advanced therapeutics
PNAS Therapeutics is a UK-based drug delivery company developing a one-step encapsulation platform designed to simplify complex pharmaceutical manufacturing processes. The platform enhances local delivery through improved bioavailability and targeting, is compatible with multiple active pharmaceutical ingredients, and…
Thermostable vaccine formulations delivered through microneedle patches
Microneedle Solutions is a biotechnology company developing vaccine-containing microneedle patches for self-administration. Its platform combines a patented needle-array manufacturing process with vaccine-loaded matrices intended to protect biological payloads and enable delivery through the skin. The company has…
Infectious disease antigens and antibodies for diagnostics and research
The Native Antigen Company is a manufacturer of native and recombinant antigens, antibodies, and immunoassays for viral and bacterial infectious disease targets. Products are supplied to IVD manufacturers, pharmaceutical companies, and academic institutions for use in immunoassay development, serology, vaccine…
Allergen immunotherapies for hay fever and food allergy
Allergy Therapeutics is a commercial biopharmaceutical company developing, manufacturing and selling immunotherapies that address the underlying immune cause of allergic disease. Its marketed products, sold across Europe, include short-course subcutaneous treatments for pollen and other respiratory allergies,…
UK manufacturer of bespoke autogenous vaccines for farm animals and fish
Ridgeway Biologicals is a UK manufacturer of bespoke veterinary vaccines prepared from pathogens extracted directly from an affected farm to control disease outbreaks in that specific animal group. Licensed by the Veterinary Medicines Directorate, the company serves the pig, poultry, ruminant and aquaculture sectors,…
Lyophilisation equipment, CDMO services, and freeze-drying expertise
Biopharma Group is a contract development and manufacturing organisation and capital equipment supplier specialising in lyophilisation and liquid formulation technologies. The company serves pharmaceutical, biotechnology, and diagnostics clients across two divisions: an equipment sales and technical service division…
Precision cancer vaccines to prevent metastatic recurrence
Infinitopes is a clinical-stage biotechnology company developing therapeutic cancer vaccines designed to prevent metastatic recurrence. Its lead candidate ITOP1 is a precision viral vector cancer vaccine targeting tumour antigens in patients with surgically resectable oesophageal adenocarcinoma, to be administered in…
Mammalian recombinant protein production and cell line development services
Daresbury Proteins is a contract research organisation specialising in mammalian recombinant protein production and cell line development. Using proprietary expression vectors optimised for CHO-K1 and HEK293 systems, the company produces difficult-to-express proteins as research reagents and candidate targets for…
Bacterial-like particle vaccine platform targeting recurrent UTIs
Spectre Bio is a biotechnology company developing a non-antibiotic prophylactic vaccine for recurrent UTIs, a major unmet medical need and significant driver of antimicrobial resistance. The company's platform produces programmable, non-replicative bacterial cells that retain a full native antigen profile while being…
Monoclonal antibodies for viral infectious disease
RQ Biotechnology is a passive immunisation company discovering and developing long-acting monoclonal antibodies to provide immediate protection against viral infections in immunocompromised and vulnerable populations. Founded by members of the UK COVID-19 Antibody Taskforce and co-founded with LifeArc, the company's…
Virus-like particle vaccine platform for infectious disease and diagnostics
iQur is a London-based biotechnology company developing vaccines using its proprietary tandem core virus-like particle platform. The technology uses the hepatitis B virus core protein to display multiple antigens simultaneously, stimulating strong immune responses without the risks of live or attenuated viruses.…
Global biopharma with major UK R&D and regulatory operations
Pfizer Limited is the principal UK subsidiary of Pfizer Inc., one of the world's largest biopharmaceutical companies. Its Sandwich, Kent site houses pharmaceutical sciences, global clinical supplies, quality assurance, and worldwide safety and regulatory operations serving over 175 markets. A Devices Centre of…
Modular automated RNA manufacturing platform
Centillion is a UK biotech company whose platform integrates synthesis, purification, and formulation stages using continuous flow chemistry to produce mRNA and self-amplifying RNA at research and production scale. The platform supports process development through to regulatory-ready CMC packages and is available as a…
AI-guided personalised mRNA cancer vaccine development
Genevation is a biotechnology company developing personalised mRNA cancer vaccines using AI-assisted tumour neoantigen identification. Its platform analyses tumour sequencing data to select patient-specific targets and combines computational vaccine design with cell-free RNA manufacturing. The company reports…
Next-generation lipid nanoparticle platform for RNA vaccines and medicines
NeoVac is a biotechnology company developing a next-generation lipid nanoparticle platform to improve the delivery of RNA vaccines and therapeutics. Its library of fully biodegradable, tissue-targeted LNPs addresses limitations of first-generation formulations, offering enhanced thermostability, multiple routes of…
AI-guided plant biosynthesis platform for novel therapeutic compounds
HotHouse Therapeutics is a drug discovery platform company that engineers plants as sustainable biofactories for pharmaceutical compound production. Using AI to design and optimise biosynthetic pathways, it produces both natural and new-to-nature molecules via transient and stable plant expression systems capable of…